These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8930400

  • 1. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A, Weixel K, Saijo N.
    Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Basu A, Lazo JS.
    Cancer Res; 1992 Jun 01; 52(11):3119-24. PubMed ID: 1591725
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C.
    Basu A, Akkaraju GR.
    Biochemistry; 1999 Apr 06; 38(14):4245-51. PubMed ID: 10194341
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL, May WS, Tyler PG, Hess AD.
    J Immunol; 1991 Nov 15; 147(10):3474-81. PubMed ID: 1834742
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
    Mohanty S, Huang J, Basu A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6730-7. PubMed ID: 16166454
    [Abstract] [Full Text] [Related]

  • 10. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 11. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.
    Clin Cancer Res; 1995 Dec 01; 1(12):1581-7. PubMed ID: 9815959
    [Abstract] [Full Text] [Related]

  • 12. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM.
    Cancer Res; 1996 May 01; 56(9):2105-11. PubMed ID: 8616857
    [Abstract] [Full Text] [Related]

  • 13. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL, Bradshaw TD, Gescher A, Pettit GR.
    Cancer Res; 1989 Jun 15; 49(12):3242-5. PubMed ID: 2720677
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 15. Properties of classic protein kinase C in human small cell lung carcinoma NCI-H345 cells.
    Jones CL, Beck LK, Brozna JP, Holley M, Dempsey EJ, Kane MA.
    Cell Growth Differ; 1995 Dec 15; 6(12):1627-34. PubMed ID: 9019168
    [Abstract] [Full Text] [Related]

  • 16. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP, Downes HF, Mirski SE, Clements DJ.
    Mol Pharmacol; 1990 Feb 15; 37(2):192-7. PubMed ID: 1968221
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.